Article3D printing and additive manufacturing2025
Therapeutic Precision: Unveiling the Potential of 3D Printing in Drug Delivery, Tissue Engineering, and Regenerative Medicine.
Article in 3D printing and additive manufacturing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Thiolated Polymers in 3D Bioprinting: Control of Gelation.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Building the next frontier: Artificial intelligence in 3D-printed medicines.Biomaterials translational · 2026Review
- Biomimetic Strategies for Nutraceutical Delivery: Advances in Bionanomedicine for Enhanced Nutritional Health.Biomimetics (Basel, Switzerland) · 2025Review
- Revealing Three-Dimensional Printing Technology Advances for Oral Drug Delivery: Application to Central-Nervous-System-Related Diseases.Pharmaceutics · 2025Review
- Therapeutic potential of microalgae-derived natural compounds in diabetic wound healing: A comprehensive review.Heliyon · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
3D printing has emerged as a groundbreaking technology with transformative applications in various health care domains. In drug delivery, it enables the precise fabrication of customized dosage forms, offering controlled release patterns and stimulus-triggered release capabilities. In addition, 3D printing plays a pivotal role in tissue engineering, facilitating the creation of complex structures with biomimetic properties. The impact of 3D printing technology extends to personalized medicine, allowing for the production of patient-specific medications tailored to individual needs. In the realm of regenerative medicine, 3D printing contributes to the fabrication of intricate scaffolds and bioprinted tissues, fostering advancements in the regeneration of damaged or diseased tissues. The versatility and precision of 3D printing make it a powerful tool across these domains, promising innovative solutions and personalized approaches in the field of health care. A comprehensive review of scholarly literature spanning from 1980 to the present was conducted across prominent databases such as PubMed, Wiley Online Library, Multidisciplinary Digital Publishing Institute, Kosmet, Science Direct, and Scopus. The present review offers a comprehensive examination of 3D printing in the biomedical and pharmaceutical sectors, shedding light on its historical progression while envisioning a future where regenerative and customized medicines become commonplace.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.